Table 2.
Plant line | PAP expressed | PAP* ng/mg | No. of lesions† | % infected‡ |
---|---|---|---|---|
WT | 0 | 77 ± 4 | 90 | |
26139-19 | PAP-v | 5.6 ± 2.6 | 0§ | 30§ |
33617-11 | PAP | 0.6 ± 0.02 | 0§ | 40¶ |
144-1 | E176V | 43.8 ± 4.8 | 78 ± 5 | 100 |
144-7 | E176V | 46.2 ± 5.6 | 72 ± 4 | 100 |
WT | 0 | 12 ± 2 | 100 | |
26139-19 | PAP-v | 9.6 ± 2.6 | 1 ± 0.3§ | 30§ |
144-6 | E176V | 1,045 ± 45 | 11 ± 2 | 100 |
144-13 | E176V | 900 ± 50 | 13 ± 3 | 100 |
Twenty plants from R1 progeny of each transgenic line were analyzed ELISA for expression of PAP and PAP-positive plants were used in virus resistance tests. Mean values ± SE are shown for each transgenic line.
Ten plants from each line were inoculated with 1 μg/ml PVX (top rows) or 0.5 μg/ml PVX (bottom rows) and the number of lesions were counted 9 days postinoculation (dpi). Mean values ± SE of the mean for the numbers of lesions per plant are shown.
Three leaf disks were taken from first, second, and third systemically infected leaves at 12 dpi, and viral antigen levels were quantitated by ELISA.
Significantly different from wild type at 1% level.
Significantly different from wild type at 5% level.